Name: Meeting - Possible Biomedical Facility at CERN
Start: 2012-06-25T08:45:00+02:00
End: 2012-06-25T18:00:00+02:00
Location: CERN

Meeting - Possible Biomedical Facility at CERN

Monday 25 June 2012 - 08:45
CERN (503/1-001)

: Sessions

: Talks

: Breaks

25 Jun 2012

08:45	--- Welcome coffee ---
09:30	Session 1 - Chairs: Steve Myers and Alberto del Guerra (until 11:00) (503/1-001 - Council Chamber)
09:30	Introduction - Steve Myers (CERN) (503/1-001 - Council Chamber) Slides
09:40	Our mission - Manjit Dosanjh (CERN) (503/1-001 - Council Chamber) Slides
09:50	LEIR - Christian Carli (CERN) (503/1-001 - Council Chamber) Slides
10:10	Hadron Radiobiology and Cancer Therapy: What Must be Done in an International Setting at CERN – Bleddyn Jones (Oxford) (503/1-001 - Council Chamber) Slides
10:30	The need for an open access radiobiology research facility - Michael Holzscheiter (UNM Albuquerque) (503/1-001 - Council Chamber) Slides
10:50	A short presentation on some thoughts for a radiobiology programme – Ken Peach (PCTRI, Oxford) (503/1-001 - Council Chamber) Slides
11:00	--- Coffee ---
11:30	Session 2 - Chairs: Sergio Bertolucci and Ken Peach (until 13:00) (503/1-001 - Council Chamber)
11:30	A personal view – Alberto Del Guerra (Pisa) (503/1-001 - Council Chamber) Slides
11:50	The needs for the Lyon groups concerning ion therapy research (imaging detector tests, radiobiology) – Denis Dauvergne (CNRS, Lyon) (503/1-001 - Council Chamber) Slides
12:10	Portuguese interest in participating in a biomedical facility at CERN complemented by radiobiological/radiophysiological studies – Paulo Crespo (LIP) (503/1-001 - Council Chamber) Slides
12:25	Dosimetry with Solid State Detectors - Experiments at LEIR? - Niels Bassler (University of Aarhus) (503/1-001 - Council Chamber) Slides
12:40	The TERA foundation - David Watts (TERA) (503/1-001 - Council Chamber) Slides

13:00	--- Lunch ---
14:00	Session 3 - Chairs: Paul Collier and Jacques Balosso (until 15:30) (503/1-001 - Council Chamber)
14:00	Research and new pre-clinical treatment methods for glioblastoma – Jean Bouhris (Head, Radiation Oncology Department, Institute Gustave Roussy) (503/1-001 - Council Chamber)
14:20	Priorities in Hadron Therapy research - Raj Jena (Cambridge University Hospitals NHS Foundation Trust) (503/1-001 - Council Chamber) Slides
14:35	Objectives and means of France HADRON in terms of facilities and beam access - Jacques Balosso (ETOILE and France Hadron) (503/1-001 - Council Chamber) Slides
14:55	TBA - Michael Waligorski (Poland) (503/1-001 - Council Chamber) Slides
15:15	Radiobiology for Hadron Therapy, Radiobiology for Radiation Protection - Roberto Cherubini (INFN-LNL) (503/1-001 - Council Chamber) Slides
15:30	Conclusions and Action Plan ( Jose Mariano Gago and Bleddyn Jones) (503/1-001 - Council Chamber)
16:30	--- Networking cocktail ---

Choose timezone